These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9362178)

  • 1. Serum hepatitis G virus RNA in patients with chronic viral hepatitis.
    Marrone A; Shih JW; Nakatsuji Y; Alter HJ; Lau D; Vergalla J; Hoofnagle JH
    Am J Gastroenterol; 1997 Nov; 92(11):1992-6. PubMed ID: 9362178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between amount of HBV DNA in serum/liver tissue and hepatitis G virus (HGV) infection in patients with chronic hepatitis B].
    Shang Q; Yu J; Zhuo H; Xu C; Wang N; Zhang G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):326-8. PubMed ID: 12665896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ribavirin plus interferon alpha on viraemia of GB virus-C/hepatitis G virus: comparison with interferon alpha alone.
    Kao JH; Lai MY; Chen W; Chen PJ; Chen DS
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1249-53. PubMed ID: 9918434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
    J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy.
    Oshita M; Hayashi N; Mita E; Iio S; Hiramatsu N; Hijioka T; Kato M; Masuzawa M; Sasaki Y; Kasahara A; Hori M
    J Med Virol; 1998 Jun; 55(2):98-102. PubMed ID: 9598928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
    Kaya S; Cicioğlu Aridoğan B; Demirci M
    Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis G virus infection in hemodialysis patients and the effects of interferon treatment.
    Umlauft F; Wong DT; Underhill PA; Oefner PJ; Jin L; Urbanek M; Gruenewald K; Greenberg HB
    Am J Gastroenterol; 1997 Nov; 92(11):1986-91. PubMed ID: 9362177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team.
    Alter MJ; Gallagher M; Morris TT; Moyer LA; Meeks EL; Krawczynski K; Kim JP; Margolis HS
    N Engl J Med; 1997 Mar; 336(11):741-6. PubMed ID: 9052651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term liver function of recipients with hepatitis G virus infection after bone marrow transplantation.
    Maruta A; Tanabe J; Hashimoto C; Kato K; Kanamori H; Fukawa H; Miyashita H; Fujisawa S; Fujita H; Matsuzaki M; Motomura S; Kodama F; Ookawa S; Mohri H; Ishigatsubo Y
    Bone Marrow Transplant; 1999 Aug; 24(4):359-63. PubMed ID: 10467323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
    Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
    Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood.
    Heuft HG; Berg T; Schreier E; Künkel U; Tacke M; Schwella N; Hopf U; Salama A; Huhn D
    Vox Sang; 1998; 74(3):161-7. PubMed ID: 9595643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis G virus RNA in human immunodeficiency virus type 1-positive intravenous drug users.
    Zehender G; De Maddalena C; Bosisio AB; Gianotto M; Santambrogio S; Moroni M; Galli M
    J Hum Virol; 1998; 1(2):96-100. PubMed ID: 10195238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa.
    Enomoto M; Nishiguchi S; Fukuda K; Kuroki T; Tanaka M; Otani S; Ogami M; Monna T
    Hepatology; 1998 May; 27(5):1388-93. PubMed ID: 9581696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatitis G virus RNA in patients with hepatitis B, hepatitis C, and non-A-E hepatitis by RT-PCR using multiple primer sets.
    Zhang XH; Shinzawa H; Shao L; Ishibashi M; Saito K; Ohno S; Yamada N; Misawa H; Togashi H; Takahashi T
    J Med Virol; 1997 Aug; 52(4):385-90. PubMed ID: 9260685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on multiple infection with hepatitis B, C and G viruses].
    Du S; Tao Q; Chang J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):13-5. PubMed ID: 10322744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver disease.
    Fried MW; Khudyakov YE; Smallwood GA; Cong M; Nichols B; Diaz E; Siefert P; Gutekunst K; Gordon RD; Boyer TD; Fields HA
    Hepatology; 1997 May; 25(5):1271-5. PubMed ID: 9141451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
    Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B
    Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
    Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
    Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.